NFE2L2 and chronic obstructive pulmonary disease: Furthermore, Nrf2 promoter hypermethylation is observed in both COPD patients and CSE-treated HBE cells, resulting in NRF2 downregulation, inhibited GPX4 expression and ferroptosis occurrence21.